Sionna Therapeutics Inc (SION)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,828 | -34,550 | -16,482 | -61,688 | -45,840 |
| Depreciation Amortization | -2,204 | -1,557 | -538 | -2,333 | -1,710 |
| Accounts payable and accrued liabilities | 295 | -272 | 3,554 | N/A | -615 |
| Other Working Capital | -2,350 | -4,249 | -1,853 | -3,075 | -6,211 |
| Other Operating Activity | 9,416 | 6,187 | -969 | 14,309 | 13,370 |
| Operating Cash Flow | $-49,671 | $-34,441 | $-16,288 | $-52,787 | $-41,006 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -141,164 | -164,353 | -141,108 | N/A | -142,141 |
| PPE Investments | -173 | -86 | -86 | -27 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -126,886 | 0 |
| Investing Cash Flow | $-141,337 | $-164,439 | $-141,194 | $-126,913 | $-142,141 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,980 | 6 | 0 | N/A | 116 |
| Other Financing Activity | 202,071 | 202,071 | 202,389 | 178,967 | 180,259 |
| Financing Cash Flow | $204,051 | $202,077 | $202,389 | $178,967 | $180,375 |
| Beginning Cash Position | 38,750 | 38,750 | 38,750 | 39,483 | 39,483 |
| End Cash Position | 51,793 | 41,947 | 83,657 | 38,750 | 36,711 |
| Net Cash Flow | $13,043 | $3,197 | $44,907 | $-733 | $-2,772 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,671 | -34,441 | -16,288 | -52,787 | -41,006 |
| Capital Expenditure | -173 | -86 | -86 | N/A | 0 |
| Free Cash Flow | -49,844 | -34,527 | -16,374 | -52,787 | -41,006 |